Association of Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination or a Prior Positive Test Result in Adolescents during the Delta Variant Surge in Kentucky - 15/09/22
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
In a cross-sectional study of 89 736 adolescents in Kentucky, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination provided an estimated protection against infection of 81% when the highly transmissible Delta variant was predominant. Vaccination provided added benefit to those with a history of prior infection. These findings support the recommendation that all adolescents receive SARS-CoV-2 vaccination.
Le texte complet de cet article est disponible en PDF.Keywords : adolescents, reinfection, vaccine-derived immunity, infection-derived immunity
Abbreviations : COVID-19, EDSS, mRNA, PR, SARS-CoV-2
Plan
| The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry or the Kentucky Department for Public Health. The authors declare no conflicts of interest. |
Vol 248
P. 119-121 - septembre 2022 Retour au numéro
Article précédent
- Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey
- Levi Hoste, MIS-C researchers, Antoni Soriano-Arandes, Emilie Pauline Buddingh, Elizabeth Whittaker, Alexandre Belot, Rolando Ulloa-Gutierrez, Peter Olbrich, Filomeen Haerynck
- Nocturnal Hypoventilation as a Respiratory Complication of Acute Flaccid Myelitis
- Razina Aziz-Bose, Sumit Bhargava, MyMy Buu, Riley Bove, Keith van Haren
Bienvenue sur EM-consulte, la référence des professionnels de santé.